Zepp Health (ZEPP) Gains from Sales and Divestitures (2016 - 2025)

Zepp Health's Gains from Sales and Divestitures history runs 9 years deep, the most recent figure standing at $1.5 million for Q4 2025.

• In Q4 2025, Gains from Sales and Divestitures changed N/A year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (changed N/A YoY), while the FY2025 annual figure was $1.5 million, up 396.81% from the prior year.
• Gains from Sales and Divestitures was $1.5 million for Q4 2025 at Zepp Health, up from $224537.0 in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $1.5 million in Q4 2025 to a low of $80968.1 in Q4 2021.
• Historically, Gains from Sales and Divestitures has averaged $489006.1 across 4 years, with a median of $201440.2 in 2022.
• The sharpest annual moves came in 2021 and 2022: Gains from Sales and Divestitures tumbled 45.63% in 2021, then surged 120.26% in 2022.
• A 4-year view of Gains from Sales and Divestitures shows it stood at $80968.1 in 2021, then soared by 120.26% to $178343.3 in 2022, then gained by 25.9% to $224537.0 in 2023, then soared by 555.65% to $1.5 million in 2025.
• The last three Gains from Sales and Divestitures figures came in at $1.5 million (Q4 2025), $224537.0 (Q4 2023), and $178343.3 (Q4 2022), per Business Quant data.